![biaoTi](/_nuxt/img/biaoTi.0d1dc71.webp)
![biaoTi](/_nuxt/img/biaoTi.0d1dc71.webp)
Part 1
Part 2
Part 3
Part 5
Swine Erysipelas Vaccine is used to prevent swine erysipelas. For pigs after weaning, the immunization period is 6 months. Swine Erysipelas Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Swine Erysipelas Vaccine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Pharmacy and Online Sale are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Swine Erysipelas Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029. Globally, Swine Erysipelas Vaccine key manufacturers include Zoetis, Merck, Boehringer Ingelheim, Qilu Animal Health, CAHIC, Chengdu Tianbang Biology, Jiujiang Bomeilai Biological, Jilin Zhengye Biological and Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd., etc. Zoetis, Merck, Boehringer Ingelheim are top 3 players and held % sales share in total in 2022. Swine Erysipelas Vaccine can be divided into Live and Inactivated, etc. Live is the mainstream product in the market, accounting for % sales share globally in 2022. Swine Erysipelas Vaccine is widely used in various fields, such as Pharmacy, Online Sale and Others,, etc. Pharmacy provides greatest supports to the Swine Erysipelas Vaccine industry development. In 2022, global % sales of Swine Erysipelas Vaccine went into Pharmacy filed. Report Scope This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Swine Erysipelas Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making. Manufacturers, Type, Application and Regions Listed in the Report: By Company Zoetis Merck Boehringer Ingelheim Qilu Animal Health CAHIC Chengdu Tianbang Biology Jiujiang Bomeilai Biological Jilin Zhengye Biological Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Segment by Type Live Inactivated Segment by Application Pharmacy Online Sale Others Segment by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE Each chapter of the report provides detailed information for readers to understand the Swine Erysipelas Vaccine market further: Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Swine Erysipelas Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Swine Erysipelas Vaccine industry. Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Swine Erysipelas Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis. Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Swine Erysipelas Vaccine introduction, etc. Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part. Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter. Chapter 12: Market Channel, Distributors and Customers are listed. Chapter 13: QYResearch’s Conclusions of Swine Erysipelas Vaccine market based on comprehensive survey. Chapter 14: Methodology and Data Sources adopted by QYResearch.
1 Swine Erysipelas Vaccine Market Overview
1.1 Swine Erysipelas Vaccine Product Overview
1.2 Swine Erysipelas Vaccine Market Segment by Type
1.2.1 Live
1.2.2 Inactivated
1.3 Global Swine Erysipelas Vaccine Market Size by Type
1.3.1 Global Swine Erysipelas Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Swine Erysipelas Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Swine Erysipelas Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Swine Erysipelas Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Swine Erysipelas Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Swine Erysipelas Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Swine Erysipelas Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Swine Erysipelas Vaccine Sales Breakdown by Type (2018-2023)2 Global Swine Erysipelas Vaccine Market Competition by Company
2.1 Global Top Players by Swine Erysipelas Vaccine Sales (2018-2023)
2.2 Global Top Players by Swine Erysipelas Vaccine Revenue (2018-2023)
2.3 Global Top Players by Swine Erysipelas Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Swine Erysipelas Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Swine Erysipelas Vaccine Market Competitive Situation and Trends
2.5.1 Swine Erysipelas Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Swine Erysipelas Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Swine Erysipelas Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Swine Erysipelas Vaccine Market
2.8 Key Manufacturers Swine Erysipelas Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion3 Swine Erysipelas Vaccine Status and Outlook by Region
3.1 Global Swine Erysipelas Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Swine Erysipelas Vaccine Historic Market Size by Region
3.2.1 Global Swine Erysipelas Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Swine Erysipelas Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Swine Erysipelas Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Swine Erysipelas Vaccine Forecasted Market Size by Region
3.3.1 Global Swine Erysipelas Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Swine Erysipelas Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Swine Erysipelas Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)4 Global Swine Erysipelas Vaccine by Application
4.1 Swine Erysipelas Vaccine Market Segment by Application
4.1.1 Pharmacy
4.1.2 Online Sale
4.1.3 Others
4.2 Global Swine Erysipelas Vaccine Market Size by Application
4.2.1 Global Swine Erysipelas Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Swine Erysipelas Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Swine Erysipelas Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Swine Erysipelas Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Swine Erysipelas Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Swine Erysipelas Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Swine Erysipelas Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Swine Erysipelas Vaccine Sales Breakdown by Application (2018-2023)5 North America Swine Erysipelas Vaccine by Country
5.1 North America Swine Erysipelas Vaccine Historic Market Size by Country
5.1.1 North America Swine Erysipelas Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Swine Erysipelas Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Swine Erysipelas Vaccine Sales in Value by Country (2018-2023)
5.2 North America Swine Erysipelas Vaccine Forecasted Market Size by Country
5.2.1 North America Swine Erysipelas Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Swine Erysipelas Vaccine Sales in Value by Country (2024-2029)6 Europe Swine Erysipelas Vaccine by Country
6.1 Europe Swine Erysipelas Vaccine Historic Market Size by Country
6.1.1 Europe Swine Erysipelas Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Swine Erysipelas Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Swine Erysipelas Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Swine Erysipelas Vaccine Forecasted Market Size by Country
6.2.1 Europe Swine Erysipelas Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Swine Erysipelas Vaccine Sales in Value by Country (2024-2029)7 Asia-Pacific Swine Erysipelas Vaccine by Region
7.1 Asia-Pacific Swine Erysipelas Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Swine Erysipelas Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Swine Erysipelas Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Swine Erysipelas Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Swine Erysipelas Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Swine Erysipelas Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Swine Erysipelas Vaccine Sales in Value by Region (2024-2029)8 Latin America Swine Erysipelas Vaccine by Country
8.1 Latin America Swine Erysipelas Vaccine Historic Market Size by Country
8.1.1 Latin America Swine Erysipelas Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Swine Erysipelas Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Swine Erysipelas Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Swine Erysipelas Vaccine Forecasted Market Size by Country
8.2.1 Latin America Swine Erysipelas Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Swine Erysipelas Vaccine Sales in Value by Country (2024-2029)9 Middle East and Africa Swine Erysipelas Vaccine by Country
9.1 Middle East and Africa Swine Erysipelas Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Swine Erysipelas Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Swine Erysipelas Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Swine Erysipelas Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Swine Erysipelas Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Swine Erysipelas Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Swine Erysipelas Vaccine Sales in Value by Country (2024-2029)10 Company Profiles
10.1 Zoetis
10.1.1 Zoetis Company Information
10.1.2 Zoetis Introduction and Business Overview
10.1.3 Zoetis Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Zoetis Swine Erysipelas Vaccine Products Offered
10.1.5 Zoetis Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Swine Erysipelas Vaccine Products Offered
10.2.5 Merck Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Boehringer Ingelheim Swine Erysipelas Vaccine Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Qilu Animal Health
10.4.1 Qilu Animal Health Company Information
10.4.2 Qilu Animal Health Introduction and Business Overview
10.4.3 Qilu Animal Health Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Qilu Animal Health Swine Erysipelas Vaccine Products Offered
10.4.5 Qilu Animal Health Recent Development
10.5 CAHIC
10.5.1 CAHIC Company Information
10.5.2 CAHIC Introduction and Business Overview
10.5.3 CAHIC Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 CAHIC Swine Erysipelas Vaccine Products Offered
10.5.5 CAHIC Recent Development
10.6 Chengdu Tianbang Biology
10.6.1 Chengdu Tianbang Biology Company Information
10.6.2 Chengdu Tianbang Biology Introduction and Business Overview
10.6.3 Chengdu Tianbang Biology Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Chengdu Tianbang Biology Swine Erysipelas Vaccine Products Offered
10.6.5 Chengdu Tianbang Biology Recent Development
10.7 Jiujiang Bomeilai Biological
10.7.1 Jiujiang Bomeilai Biological Company Information
10.7.2 Jiujiang Bomeilai Biological Introduction and Business Overview
10.7.3 Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Products Offered
10.7.5 Jiujiang Bomeilai Biological Recent Development
10.8 Jilin Zhengye Biological
10.8.1 Jilin Zhengye Biological Company Information
10.8.2 Jilin Zhengye Biological Introduction and Business Overview
10.8.3 Jilin Zhengye Biological Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Jilin Zhengye Biological Swine Erysipelas Vaccine Products Offered
10.8.5 Jilin Zhengye Biological Recent Development
10.9 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd.
10.9.1 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Company Information
10.9.2 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Introduction and Business Overview
10.9.3 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Products Offered
10.9.5 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Recent Development
10.10 Hunan Zhong'an Biological Pharmaceutical Co., Ltd.
10.10.1 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Company Information
10.10.2 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Introduction and Business Overview
10.10.3 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Products Offered
10.10.5 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Recent Development11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Swine Erysipelas Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Swine Erysipelas Vaccine Industrial Chain Analysis
11.4 Swine Erysipelas Vaccine Market Dynamics
11.4.1 Swine Erysipelas Vaccine Industry Trends
11.4.2 Swine Erysipelas Vaccine Market Drivers
11.4.3 Swine Erysipelas Vaccine Market Challenges
11.4.4 Swine Erysipelas Vaccine Market Restraints12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Swine Erysipelas Vaccine Distributors
12.3 Swine Erysipelas Vaccine Downstream Customers13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables Table 1. Major Company of Live Table 2. Major Company of Inactivated Table 3. Global Swine Erysipelas Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million) Table 4. Global Swine Erysipelas Vaccine Sales by Type (2018-2023) & (K Units) Table 5. Global Swine Erysipelas Vaccine Sales Market Share in Volume by Type (2018-2023) Table 6. Global Swine Erysipelas Vaccine Sales by Type (2018-2023) & (US& Million) Table 7. Global Swine Erysipelas Vaccine Market Share in Value by Type (2018-2023) Table 8. Global Swine Erysipelas Vaccine Price by Type (2018-2023) & (US$/Unit) Table 9. Global Swine Erysipelas Vaccine Sales by Type (2024-2029) & (K Units) Table 10. Global Swine Erysipelas Vaccine Sales Market Share in Volume by Type (2024-2029) Table 11. Global Swine Erysipelas Vaccine Sales by Type (2024-2029) & (US$ Million) Table 12. Global Swine Erysipelas Vaccine Sales Market Share in Value by Type (2024-2029) Table 13. Global Swine Erysipelas Vaccine Price by Type (2024-2029) & (US$/Unit) Table 14. North America Swine Erysipelas Vaccine Sales by Type (2018-2023) & (K Units) Table 15. North America Swine Erysipelas Vaccine Sales by Type (2018-2023) & (US$ Million) Table 16. Europe Swine Erysipelas Vaccine Sales (K Units) by Type (2018-2023) Table 17. Europe Swine Erysipelas Vaccine Sales by Type (2018-2023) & (US$ Million) Table 18. Asia-Pacific Swine Erysipelas Vaccine Sales (K Units) by Type (2018-2023) Table 19. Asia-Pacific Swine Erysipelas Vaccine Sales by Type (2018-2023) & (US$ Million) Table 20. Latin America Swine Erysipelas Vaccine Sales (K Units) by Type (2018-2023) Table 21. Latin America Swine Erysipelas Vaccine Sales by Type (2018-2023) & (US$ Million) Table 22. Middle East and Africa Swine Erysipelas Vaccine Sales (K Units) by Type (2018-2023) Table 23. Middle East and Africa Swine Erysipelas Vaccine Sales by Type (2018-2023) & (US$ Million) Table 24. Global Swine Erysipelas Vaccine Sales by Company (2018-2023) & (K Units) Table 25. Global Swine Erysipelas Vaccine Sales Share by Company (2018-2023) Table 26. Global Swine Erysipelas Vaccine Revenue by Company (2018-2023) & (US$ Million) Table 27. Global Swine Erysipelas Vaccine Revenue Share by Company (2018-2023) Table 28. Global Market Swine Erysipelas Vaccine Price by Company (2018-2023) & (US$/Unit) Table 29. Global Swine Erysipelas Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area Table 30. Global Swine Erysipelas Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Swine Erysipelas Vaccine as of 2022) Table 32. Date of Key Manufacturers Enter into Swine Erysipelas Vaccine Market Table 33. Key Manufacturers Swine Erysipelas Vaccine Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Swine Erysipelas Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029 Table 36. Global Swine Erysipelas Vaccine Sales by Region (2018-2023) & (K Units) Table 37. Global Swine Erysipelas Vaccine Sales Market Share in Volume by Region (2018-2023) Table 38. Global Swine Erysipelas Vaccine Sales by Region (2018-2023) & (US$ Million) Table 39. Global Swine Erysipelas Vaccine Sales Market Share in Value by Region (2018-2023) Table 40. Global Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 41. Global Swine Erysipelas Vaccine Sales by Region (2024-2029) & (K Units) Table 42. Global Swine Erysipelas Vaccine Sales Market Share in Volume by Region (2024-2029) Table 43. Global Swine Erysipelas Vaccine Sales by Region (2024-2029) & (US$ Million) Table 44. Global Swine Erysipelas Vaccine Sales Market Share in Value by Region (2024-2029) Table 45. Global Swine Erysipelas Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029) Table 46. Global Swine Erysipelas Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million) Table 47. Global Swine Erysipelas Vaccine Sales by Application (2018-2023) & (K Units) Table 48. Global Swine Erysipelas Vaccine Sales Market Share in Volume by Application (2018-2023) Table 49. Global Swine Erysipelas Vaccine Sales by Application (2018-2023) & (US$ Million) Table 50. Global Swine Erysipelas Vaccine Sales Market Share in Value by Application (2018-2023) Table 51. Global Swine Erysipelas Vaccine Price by Application (2018-2023) & (US$/Unit) Table 52. Global Swine Erysipelas Vaccine Sales by Application (2024-2029) & (K Units) Table 53. Global Swine Erysipelas Vaccine Sales Market Share in Volume by Application (2024-2029) Table 54. Global Swine Erysipelas Vaccine Sales by Application (2024-2029) & (US$ Million) Table 55. Global Swine Erysipelas Vaccine Sales Market Share in Value by Application (2024-2029) Table 56. Global Swine Erysipelas Vaccine Price by Application (2024-2029) & (US$/Unit) Table 57. North America Swine Erysipelas Vaccine Sales by Application (2018-2023) (K Units) Table 58. North America Swine Erysipelas Vaccine Sales by Application (2018-2023) & (US$ Million) Table 59. Europe Swine Erysipelas Vaccine Sales by Application (2018-2023) (K Units) Table 60. Europe Swine Erysipelas Vaccine Sales by Application (2018-2023) & (US$ Million) Table 61. Asia-Pacific Swine Erysipelas Vaccine Sales by Application (2018-2023) (K Units) Table 62. Asia-Pacific Swine Erysipelas Vaccine Sales by Application (2018-2023) & (US$ Million) Table 63. Latin America Swine Erysipelas Vaccine Sales by Application (2018-2023) (K Units) Table 64. Latin America Swine Erysipelas Vaccine Sales by Application (2018-2023) & (US$ Million) Table 65. Middle East and Africa Swine Erysipelas Vaccine Sales by Application (2018-2023) (K Units) Table 66. Middle East and Africa Swine Erysipelas Vaccine Sales by Application (2018-2023) & (US$ Million) Table 67. North America Swine Erysipelas Vaccine Sales by Country (2018-2023) & (K Units) Table 68. North America Swine Erysipelas Vaccine Sales Market Share in Volume by Country (2018-2023) Table 69. North America Swine Erysipelas Vaccine Sales by Country (2018-2023) & (US$ Million) Table 70. North America Swine Erysipelas Vaccine Sales Market Share in Value by Country (2018-2023) Table 71. North America Swine Erysipelas Vaccine Sales by Country (2024-2029) & (K Units) Table 72. North America Swine Erysipelas Vaccine Sales Market Share in Volume by Country (2024-2029) Table 73. North America Swine Erysipelas Vaccine Sales by Country (2024-2029) & (US$ Million) Table 74. North America Swine Erysipelas Vaccine Sales Market Share in Value by Country (2024-2029) Table 75. Europe Swine Erysipelas Vaccine Sales by Country (2018-2023) & (K Units) Table 76. Europe Swine Erysipelas Vaccine Sales Market Share in Volume by Country (2018-2023) Table 77. Europe Swine Erysipelas Vaccine Sales by Country (2018-2023) & (US$ Million) Table 78. Europe Swine Erysipelas Vaccine Sales Market Share in Value by Country (2018-2023) Table 79. Europe Swine Erysipelas Vaccine Sales by Country (2024-2029) & (K Units) Table 80. Europe Swine Erysipelas Vaccine Sales Market Share in Volume by Country (2024-2029) Table 81. Europe Swine Erysipelas Vaccine Sales by Country (2024-2029) & (US$ Million) Table 82. Europe Swine Erysipelas Vaccine Sales Market Share in Value by Country (2024-2029) Table 83. Asia-Pacific Swine Erysipelas Vaccine Sales by Region (2018-2023) & (K Units) Table 84. Asia-Pacific Swine Erysipelas Vaccine Sales Market Share in Volume by Region (2018-2023) Table 85. Asia-Pacific Swine Erysipelas Vaccine Sales by Region (2018-2023) & (US$ Million) Table 86. Asia-Pacific Swine Erysipelas Vaccine Sales Market Share in Value by Region (2018-2023) Table 87. Asia-Pacific Swine Erysipelas Vaccine Sales by Region (2024-2029) & (K Units) Table 88. Asia-Pacific Swine Erysipelas Vaccine Sales Market Share in Volume by Region (2024-2029) Table 89. Asia-Pacific Swine Erysipelas Vaccine Sales by Region (2024-2029) & (US$ Million) Table 90. Asia-Pacific Swine Erysipelas Vaccine Sales Market Share in Value by Region (2024-2029) Table 91. Latin America Swine Erysipelas Vaccine Sales by Country (2018-2023) & (K Units) Table 92. Latin America Swine Erysipelas Vaccine Sales Market Share in Volume by Country (2018-2023) Table 93. Latin America Swine Erysipelas Vaccine Sales by Country (2018-2023) & (US$ Million) Table 94. Latin America Swine Erysipelas Vaccine Sales Market Share in Value by Country (2018-2023) Table 95. Latin America Swine Erysipelas Vaccine Sales by Country (2024-2029) & (K Units) Table 96. Latin America Swine Erysipelas Vaccine Sales Market Share in Volume by Country (2024-2029) Table 97. Latin America Swine Erysipelas Vaccine Sales by Country (2024-2029) & (US$ Million) Table 98. Latin America Swine Erysipelas Vaccine Sales Market Share in Value by Country (2024-2029) Table 99. Middle East and Africa Swine Erysipelas Vaccine Sales by Country (2018-2023) & (K Units) Table 100. Middle East and Africa Swine Erysipelas Vaccine Sales Market Share in Volume by Country (2018-2023) Table 101. Middle East and Africa Swine Erysipelas Vaccine Sales by Country (2018-2023) & (US$ Million) Table 102. Middle East and Africa Swine Erysipelas Vaccine Sales Market Share in Value by Country (2018-2023) Table 103. Middle East and Africa Swine Erysipelas Vaccine Sales by Country (2024-2029) & (K Units) Table 104. Middle East and Africa Swine Erysipelas Vaccine Sales Market Share in Volume by Country (2024-2029) Table 105. Middle East and Africa Swine Erysipelas Vaccine Sales by Country (2024-2029) & (US$ Million) Table 106. Middle East and Africa Swine Erysipelas Vaccine Sales Market Share in Value by Country (2024-2029) Table 107. Zoetis Company Information Table 108. Zoetis Introduction and Business Overview Table 109. Zoetis Swine Erysipelas Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 110. Zoetis Swine Erysipelas Vaccine Product Table 111. Zoetis Recent Development Table 112. Merck Company Information Table 113. Merck Introduction and Business Overview Table 114. Merck Swine Erysipelas Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 115. Merck Swine Erysipelas Vaccine Product Table 116. Merck Recent Development Table 117. Boehringer Ingelheim Company Information Table 118. Boehringer Ingelheim Introduction and Business Overview Table 119. Boehringer Ingelheim Swine Erysipelas Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 120. Boehringer Ingelheim Swine Erysipelas Vaccine Product Table 121. Boehringer Ingelheim Recent Development Table 122. Qilu Animal Health Company Information Table 123. Qilu Animal Health Introduction and Business Overview Table 124. Qilu Animal Health Swine Erysipelas Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 125. Qilu Animal Health Swine Erysipelas Vaccine Product Table 126. Qilu Animal Health Recent Development Table 127. CAHIC Company Information Table 128. CAHIC Introduction and Business Overview Table 129. CAHIC Swine Erysipelas Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 130. CAHIC Swine Erysipelas Vaccine Product Table 131. CAHIC Recent Development Table 132. Chengdu Tianbang Biology Company Information Table 133. Chengdu Tianbang Biology Introduction and Business Overview Table 134. Chengdu Tianbang Biology Swine Erysipelas Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 135. Chengdu Tianbang Biology Swine Erysipelas Vaccine Product Table 136. Chengdu Tianbang Biology Recent Development Table 137. Jiujiang Bomeilai Biological Company Information Table 138. Jiujiang Bomeilai Biological Introduction and Business Overview Table 139. Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 140. Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Product Table 141. Jiujiang Bomeilai Biological Recent Development Table 142. Jilin Zhengye Biological Company Information Table 143. Jilin Zhengye Biological Introduction and Business Overview Table 144. Jilin Zhengye Biological Swine Erysipelas Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 145. Jilin Zhengye Biological Swine Erysipelas Vaccine Product Table 146. Jilin Zhengye Biological Recent Development Table 147. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Company Information Table 148. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Introduction and Business Overview Table 149. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 150. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Product Table 151. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Recent Development Table 152. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Company Information Table 153. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Introduction and Business Overview Table 154. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 155. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Product Table 156. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Recent Development Table 157. Key Raw Materials Lists Table 158. Raw Materials Key Suppliers Lists Table 159. Swine Erysipelas Vaccine Market Trends Table 160. Swine Erysipelas Vaccine Market Drivers Table 161. Swine Erysipelas Vaccine Market Challenges Table 162. Swine Erysipelas Vaccine Market Restraints Table 163. Swine Erysipelas Vaccine Distributors List Table 164. Swine Erysipelas Vaccine Downstream Customers Table 165. Research Programs/Design for This Report Table 166. Key Data Information from Secondary Sources Table 167. Key Data Information from Primary Sources List of Figures Figure 1. Swine Erysipelas Vaccine Product Picture Figure 2. Global Swine Erysipelas Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million) Figure 3. Global Swine Erysipelas Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million) Figure 4. Global Swine Erysipelas Vaccine Sales Status and Outlook (2018-2029) & (K Units) Figure 5. Product Picture of Live Figure 6. Global Live Sales YoY Growth (2018-2029) & (K Units) Figure 7. Product Picture of Inactivated Figure 8. Global Inactivated Sales YoY Growth (2018-2029) & (K Units) Figure 9. Global Swine Erysipelas Vaccine Sales by Type (2018-2029) & (US$ Million) Figure 10. Global Swine Erysipelas Vaccine Sales Market Share by Type in 2022 & 2029 Figure 11. North America Swine Erysipelas Vaccine Sales Market Share in Volume by Type in 2022 Figure 12. North America Swine Erysipelas Vaccine Sales Market Share in Value by Type in 2022 Figure 13. Europe Swine Erysipelas Vaccine Sales Market Share in Volume by Type in 2022 Figure 14. Europe Swine Erysipelas Vaccine Sales Market Share in Value by Type in 2022 Figure 15. Asia-Pacific Swine Erysipelas Vaccine Sales Market Share in Volume by Type in 2022 Figure 16. Asia-Pacific Swine Erysipelas Vaccine Sales Market Share in Value by Type in 2022 Figure 17. Latin America Swine Erysipelas Vaccine Sales Market Share in Volume by Type in 2022 Figure 18. Latin America Swine Erysipelas Vaccine Sales Market Share in Value by Type in 2022 Figure 19. Middle East and Africa Swine Erysipelas Vaccine Sales Market Share in Volume by Type in 2022 Figure 20. Middle East and Africa Swine Erysipelas Vaccine Sales Market Share in Value by Type in 2022 Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Swine Erysipelas Vaccine Sales in 2022 Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Swine Erysipelas Vaccine Revenue in 2022 Figure 23. Swine Erysipelas Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022 Figure 24. Product Picture of Pharmacy Figure 25. Global Pharmacy Sales YoY Growth (2018-2029) & (K Units) Figure 26. Product Picture of Online Sale Figure 27. Global Online Sale Sales YoY Growth (2018-2029) & (K Units) Figure 28. Product Picture of Others Figure 29. Global Others Sales YoY Growth (2018-2029) & (K Units) Figure 30. Global Swine Erysipelas Vaccine Sales by Application (2018-2029) & (US$ Million) Figure 31. Global Swine Erysipelas Vaccine Sales Market Share by Application in 2022 & 2029 Figure 32. North America Swine Erysipelas Vaccine Sales Market Share in Volume by Application in 2022 Figure 33. North America Swine Erysipelas Vaccine Sales Market Share in Value by Application in 2022 Figure 34. Europe Swine Erysipelas Vaccine Sales Market Share in Volume by Application in 2022 Figure 35. Europe Swine Erysipelas Vaccine Sales Market Share in Value by Application in 2022 Figure 36. Asia-Pacific Swine Erysipelas Vaccine Sales Market Share in Volume by Application in 2022 Figure 37. Asia-Pacific Swine Erysipelas Vaccine Sales Market Share in Value by Application in 2022 Figure 38. Latin America Swine Erysipelas Vaccine Sales Market Share in Volume by Application in 2022 Figure 39. Latin America Swine Erysipelas Vaccine Sales Market Share in Value by Application in 2022 Figure 40. Middle East and Africa Swine Erysipelas Vaccine Sales Market Share in Value by Application in 2022 Figure 41. Key Raw Materials Price Figure 42. Swine Erysipelas Vaccine Manufacturing Cost Structure Figure 43. Swine Erysipelas Vaccine Industrial Chain Analysis Figure 44. Channels of Distribution Figure 45. Distributors Profiles Figure 46. Bottom-up and Top-down Approaches for This Report Figure 47. Data Triangulation Figure 48. Key Executives Interviewed
Swine Erysipelas Vaccine is used to prevent swine erysipelas. For pigs after weaning, the immunization period is 6 months. Swine Erysipelas Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Swine Erysipelas Vaccine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Pharmacy and Online Sale are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Swine Erysipelas Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029. Globally, Swine Erysipelas Vaccine key manufacturers include Zoetis, Merck, Boehringer Ingelheim, Qilu Animal Health, CAHIC, Chengdu Tianbang Biology, Jiujiang Bomeilai Biological, Jilin Zhengye Biological and Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd., etc. Zoetis, Merck, Boehringer Ingelheim are top 3 players and held % sales share in total in 2022. Swine Erysipelas Vaccine can be divided into Live and Inactivated, etc. Live is the mainstream product in the market, accounting for % sales share globally in 2022. Swine Erysipelas Vaccine is widely used in various fields, such as Pharmacy, Online Sale and Others,, etc. Pharmacy provides greatest supports to the Swine Erysipelas Vaccine industry development. In 2022, global % sales of Swine Erysipelas Vaccine went into Pharmacy filed. Report Scope This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Swine Erysipelas Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making. Manufacturers, Type, Application and Regions Listed in the Report: By Company Zoetis Merck Boehringer Ingelheim Qilu Animal Health CAHIC Chengdu Tianbang Biology Jiujiang Bomeilai Biological Jilin Zhengye Biological Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Segment by Type Live Inactivated Segment by Application Pharmacy Online Sale Others Segment by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE Each chapter of the report provides detailed information for readers to understand the Swine Erysipelas Vaccine market further: Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Swine Erysipelas Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Swine Erysipelas Vaccine industry. Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Swine Erysipelas Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis. Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Swine Erysipelas Vaccine introduction, etc. Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part. Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter. Chapter 12: Market Channel, Distributors and Customers are listed. Chapter 13: QYResearch’s Conclusions of Swine Erysipelas Vaccine market based on comprehensive survey. Chapter 14: Methodology and Data Sources adopted by QYResearch.
USD 3350.00
USD 5025.00
USD 6700.00
Add to Cart
Buy Now
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now